BNP Paribas Financial Markets’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
BNP Paribas Financial Markets's TWST Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Twist Bioscience (TWST) stake by 9.5% in Q2 2026, selling an estimated $3.74M and leaving 546,647 shares worth $56.2M. The position accounts for 0.02% of the portfolio, ranked #710.
BNP Paribas Financial Markets first reported a position in TWST in Q2 2019 and has held it in 29 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.
- BNP Paribas Financial Markets held 546,647 shares of Twist Bioscience worth $56.2M as of Q2 2026.
- BNP Paribas Financial Markets sold 57,400 Twist Bioscience shares in Q2 2026, an estimated $3.74M.
- Twist Bioscience made up 0.02% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #710 holding.
- BNP Paribas Financial Markets first reported a position in Twist Bioscience in Q2 2019 and has held it in 29 quarters since.
- 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.